Resultados globales: 3 registros encontrados en 0.01 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
7 p, 473.0 KB Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party / Penack, Olaf (Charité - Universitätsmedizin Berlin) ; Peczynski, Christophe (EBMT Statistical Unit) ; van der Werf, Steffie (EBMT Data Office) ; Finke, Jürgen (University of Freiburg) ; Ganser, Arnold (Hannover Medical School) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Pavlu, Jiri (Imperial College London) ; Niittyvuopio, Riitta. (HUCH Comprehensive Cancer Center) ; Schroyens, Wilfried (University Hospital Antwerp (Bèlgica)) ; Kaynar, Leylagül (Erciyes University Medical Faculty) ; Blau, Igor W. (Charité - Universitätsmedizin Berlin) ; van der Velden, Walter (Radboud University - Nijmegen Medical Centre) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Cortelezzi, Agostino (Fondazione IRCCS - Ca'Granda) ; Wulf, Gerald (Universitätsklinikum Göttingen) ; Turlure, Pascal (CHRU Limoges) ; Rovira, Montserrat (Hospital Clínic i Provincial de Barcelona) ; Ozkurt, Zubeydenur (Gazi University) ; Pascual-Cascon, Maria J. (Hospital Regional Universitario de Málaga) ; Moreira, Maria C. (Instituto National do Cancer) ; Clausen, Johannes (Ordensklinikum Linz Elisabethinen) ; Greinix, Hildegard (LKH - University Hospital Graz) ; Duarte, Rafael F. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Basak, Grzegorz (Medical University of Warsaw) ; Universitat Autònoma de Barcelona
ric acid is a danger signal contributing to inflammation. Its relevance to allogeneic stem cell transplantation (alloSCT) derives from preclinical models where the depletion of uric acid led to improved survival and reduced graft-versus-host disease (GvHD). [...]
2020 - 10.3324/haematol.2019.228668
Haematologica, Vol. 105 Núm. 7 (january 2020) , p. 1977-1983  
2.
8 p, 3.0 MB Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party / Penack, Olaf (Charité - Universitätsmedizin Berlin) ; Peczynski, Christophe (EBMT Statistical Unit) ; van der Werf, Steffie (EBMT Data Office) ; Finke, Jürgen (University of Freiburg) ; Ganser, Arnold (Hannover Medical School) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Pavlu, Jiri (Imperial College London) ; Niittyvuopio, Riitta (HUCH Comprehensive Cancer Center) ; Schroyens, W.ilfried (University Hospital Antwerp (Bèlgica)) ; Kaynar, Leylagül (Erciyes University) ; Blau, Igor W. (Department of Hematology. Oncology. and Tumor Immunology) ; van der Velden, Walter J.F.M. (Radboud University) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Cortelezzi, Agostini (University of Milan) ; Wulf, Gerald (Universitätsklinikum Göttingen) ; Turlure, Pascal (CHRU Limoges) ; Rovira Argelagués, Montserrat (Hospital Clínic i Provincial de Barcelona) ; Ozkurt, Zubeydenur (Gazi University) ; Pascual-Cascon, Maria J. (Hospital Regional Universitario de Málaga) ; Moreira, Maria C. (Instituto National do Cancer) ; Clausen, Johannes (Ordensklinikum Linz Elisabethinen) ; Greinix, Hildegard (Medical University of Graz) ; Duarte, Rafael F. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Basak, Grzegorz (Medical University of Warsaw) ; Universitat Autònoma de Barcelona
Elevated serum ferritin levels occur due to iron overload or during inflammation and macrophage activation. A correlation of high serum ferritin levels with increased mortality after alloSCT has been suggested by several retrospective analyses as well as by two smaller prospective studies. [...]
2020 - 10.3389/fimmu.2020.00586
Frontiers in immunology, Vol. 11 (15 2020) , p. 586  
3.
12 p, 1.1 MB The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants / Rio-Machin, Ana (Queen Mary University of London) ; Vulliamy, Tom (Queen Mary University of London) ; Hug, Nele (University of Edinburgh) ; Walne, Amanda (Queen Mary University of London) ; Tawana, Kiran (Addenbrookes Hospital (Cambridge, Regne Unit)) ; Cardoso, Shirleny (Queen Mary University of London) ; Ellison, Alicia (Queen Mary University of London) ; Pontikos, Nikolas (Queen Mary University of London) ; Wang, Jun (Queen Mary University of London) ; Tummala, Hemanth (Queen Mary University of London) ; Al Seraihi, Ahad Fahad H. (Queen Mary University of London) ; Alnajar, Jenna (Queen Mary University of London) ; Bewicke-Copley, Findlay (Queen Mary University of London) ; Armes, Hannah (Queen Mary University of London) ; Barnett, Michael (University of British Columbia) ; Bloor, Adrian (Christie Hospital) ; Bödör, Csaba (Semmelweis University) ; Bowen, David (St James's University Hospital) ; Fenaux, Pierre (Université Paris) ; Green, Andrew (Our Lady's Children's Hospital) ; Hallahan, Andrew (Queensland Children's Hospital (Austràlia)) ; Hjorth-Hansen, Henrik (St Norwegian University of Science and Technology) ; Hossain, Upal (Barts NHS Trust) ; Killick, Sally (Royal Bournemouth General Hospital (Dorset, Regne Unit)) ; Lawson, Sarah (Birmingham Children's Hospital) ; Layton, Mark (Hammersmith Hospital (Londres)) ; Male, Alison M. (Great Ormond Street Hospital for Children (Londres)) ; Marsh, Judith (King's College Hospital NHS Foundation Trust) ; Mehta, Priyanka (University Hospitals Bristol NHS Foundation Trust) ; Mous, Rogier (Universitair Medisch Centrum Utrecht) ; Nomdedeu, Josep (Institut d'Investigació Biomèdica Sant Pau) ; Owen, Carolyn (Foothills Medical Centre) ; Pavlu, Jiri (Hammersmith Hospital (Londres)) ; Payne, Elspeth M. (University College London) ; Protheroe, Rachel E. (University Hospitals Bristol NHS Foundation Trust) ; Preudhomme, Claude (Universitaire de Lille. Jean-Pierre Aubert Research Center) ; Pujol-Moix, Nuria (Institut d'Investigació Biomèdica Sant Pau) ; Renneville, Aline (Broad Institute of MIT and Harvard) ; Russell, Nigel (Nottingham University Hospitals NHS Trust (Regne Unit)) ; Saggar, Anand (St George's Hospital Medical School) ; Sciuccati, Gabriela (Hospital de Pediatría "Prof. Dr. Juan P. Garrahan") ; Taussig, David (Royal Marsden Hospital (Regne Unit)) ; Toze, Cynthia L. (University of British Columbia) ; Uyttebroeck, Anne (University Hospitals Leuven (Bèlgica)) ; Vandenberghe, Peter (University Hospitals Leuven (Bèlgica)) ; Schlegelberger, Brigitte (Medizinische Hochschule Hannover) ; Ripperger, Tim (Medizinische Hochschule Hannover) ; Steinemann, Doris (Medizinische Hochschule Hannover) ; Wu, John (British Columbia Children's Hospital (Vancouver, Canadà)) ; Mason, Joanne (Birmingham Women's NHS Foundation Trust) ; Page, Paula (Birmingham Women's NHS Foundation Trust) ; Akiki, Susanna (Qatar Rehabilitation Institute) ; Reay, Kim (Birmingham Women's NHS Foundation Trust) ; Cavenagh, Jamie D. (Barts NHS Trust) ; Plagnol, Vincent (University College London) ; Caceres, Javier F. (University of Edinburgh) ; Fitzgibbon, Jude (Queen Mary University of London) ; Dokal, Inderjeet (Barts Health NHS Trust) ; Universitat Autònoma de Barcelona
The inclusion of familial myeloid malignancies as a separate disease entity in the revised WHO classification has renewed efforts to improve the recognition and management of this group of at risk individuals. [...]
2020 - 10.1038/s41467-020-14829-5
Nature communications, Vol. 11 (february 2020)  

Vea también: autores con nombres similares
1 Pavlu, J.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.